Pages that link to "Item:Q1619565"
From MaRDI portal
The following pages link to Evaluating the efficacies of maximum tolerated dose and metronomic chemotherapies: a mathematical approach (Q1619565):
Displaying 10 items.
- A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results (Q263411) (← links)
- Mathematical and numerical analysis for a model of growing metastatic tumors (Q1009602) (← links)
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy (Q1569917) (← links)
- Understanding the antiangiogenic effect of metronomic chemotherapy through a simple mathematical model (Q1620068) (← links)
- The dose-dense principle in chemotherapy (Q1705272) (← links)
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
- An optimal control problem of immuno-chemotherapy in presence of gene therapy (Q2671158) (← links)
- The influence of toxicity constraints in models of chemotherapeutic protocol escalation (Q3105810) (← links)
- USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS (Q4933727) (← links)
- Mathematical modeling and analysis on the effects of surgery and chemotherapy on lung cancer (Q6168385) (← links)